GSK plc ( GSK) - Key Metrics
GSK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.14 | $0.16 | $0.52 | $0.38 |
| 2025Q3 | $2.12 | $0.50 | $0.55 | $0.33 |
| 2025Q2 | $1.97 | $0.36 | $0.52 | $0.36 |
| 2025Q1 | $1.84 | $0.40 | $0.28 | $0.17 |
GSK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 101.57% | 28.82 |
| 2025Q3 | 32.29% | 7.89 |
| 2025Q2 | 45.46% | 9.78 |
| 2025Q1 | 37.68% | 9.20 |
GSK Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.83% | ? |
| 2025Q4 | 4.04% | 0.88% |
| 2025Q3 | 4.02% | 1.02% |
| 2025Q2 | 2.57% | 1.16% |
| 2025Q1 | 1.14% | 1.02% |
GSK
Price: $51.06
Dividend Yield: 3.62%
Forward Dividend Yield: 3.54%
Payout Ratio: 52.47%
Dividend Per Share: 1.80 USD
Earnings Per Share: 3.86 USD
P/E Ratio: 13.05
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Volume: 3.7 million
Ebitda: 2.0 billionMarket Capitalization: 100.0 billion
Average Dividend Frequency: 4
Years Paying Dividends: 43
DGR3: 0.42%
DGR5: 0.12%
DGR10: -2.10%
DGR20: 1.63%